Jeff Ubben: VRX And AGN A ‘Perfect Match’

0

One of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX)’s top shareholders on Tuesday threw his support behind its proposed takeover bid with a high-profile activist investor for Botox-maker Allergan, Inc. (NYSE:AGN).

“Allergan, Inc. (NYSE:AGN) and Valeant are a perfect match,” said hedge fund manager Jeff Ubben in an interview with CNBC. “We think it’s a really, really powerful combination.”

Trident Fund LP February 2021 Performance Update

Trident Fund LP PerformanceTrident Fund LP performance update for the month ended February 2021. Q4 2020 hedge fund letters, conferences and more Trident Fund LP Performance The Trident Fund LP returned 6.1 percent in February, and the fund is -0.5  percent net for 2021. In February, Trident profited from rising interest rates and commodity prices to regain losses sustained Read More


No posts to display